Learning Objectives:

1. Understand how children with cancer access novel agents.

2. Understand efforts to improve how novel agents are developed in children with cancer.

3. Understand potential impact of recent legislative efforts on pediatric cancer drug development.

Session date: 
09/19/2019 - 12:00pm to 1:00pm CDT
ucmc L-168
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Steven DuBois, MD, MS